<DOC>
	<DOCNO>NCT00271245</DOCNO>
	<brief_summary>The purpose study determine whether patient liver cirrhosis improve selenium nutritional status take supplemental selenium .</brief_summary>
	<brief_title>Selenium Supplementation Patients With Cirrhosis</brief_title>
	<detailed_description>Selenium essential nutrient . Selenium carry biological function selenoproteins . The liver convert dietary selenium form use make selenoproteins . Patients cirrhosis much low selenium level healthy individual . We hypothesize patient cirrhosis unable utilize dietary selenium selenoprotein synthesis . These patient may benefit another form selenium : selenate . We compare effect two supplemental form selenium plasma selenium level patient cirrhosis . Patients randomize receive either placebo , 200 µg selenomethionine , 200 µg selenate 400 µg selenate , daily , 8 week . We measure selenium level blood baseline , week 4 week 8 . We determine form selenium , , increase plasma selenium level cirrhosis patient .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Selenic Acid</mesh_term>
	<criteria>liver disease age 18 substance abuse renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>liver disease</keyword>
	<keyword>selenium</keyword>
	<keyword>selenoproteins</keyword>
	<keyword>selenoprotein P</keyword>
	<keyword>biomarkers</keyword>
</DOC>